Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study
- PMID: 30673698
- PMCID: PMC6343945
- DOI: 10.1371/journal.pone.0208736
Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study
Abstract
Background: Decreased lung function is associated with non-alcoholic fatty liver disease (NAFLD), based on linking mechanisms such as insulin resistance and systemic inflammation However, its association with the risk of developing NAFLD is unclear. Our aim was to investigate whether baseline lung function is associated with incident NAFLD in middle-aged healthy Koreans.
Methods: A cohort study of 96,104 subjects (mean age: 35.7 years) without NAFLD were followed up from 2002 to 2015. NAFLD was diagnosed by ultrasound after the exclusion of other possible causes of liver diseases. Baseline percent predicted forced expiratory volume in one second (FEV1%) and forced vital capacity (FVC%) were categorized in quartiles. Adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) (using the highest quartile as reference) were calculated for incident NAFLD at follow-up, controlling for covariates and potential confounders.
Results: During 579,714.5 person-years of follow-up, 24,450 participants developed NAFLD (incidence rate, 42.2 per 1,000 person-years). The mean follow-up period was 5.9±3.4 years. Regardless of smoking history, the risk for incident NAFLD increased with decreasing quartiles of FEV1 (%) and FVC (%) in a dose-response manner (p for trend<0.001). In never smokers, the aHRs (95% CIs) for incident NAFLD were 1.15 (1.08-1.21), 1.11 (1.05-1.18), and 1.08 (1.02-1.14) in quartiles 1-3 for FEV1 (%) and 1.12 (1.06-1.18), 1.11 (1.05-1.18), and 1.09 (1.03-1.15) in quartiles 1-3 for FVC (%), compared with the highest quartile reference. Similar inverse association was present in smoke-exposed subjects (aHR for incident NAFLD were 1.14, 1.21, 1.13 and 1.17, 1.11, 1.09 across FEV1(%) and FVC(%) quartile in increasing order, respectively).
Conclusions: Reduced lung function was a risk factor for incident NAFLD in a large middle-aged Korean cohort with over half a million person-years of follow-up.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese.BMC Endocr Disord. 2017 Mar 22;17(1):18. doi: 10.1186/s12902-017-0168-4. BMC Endocr Disord. 2017. PMID: 28330472 Free PMC article.
-
Inverse association between lung function and nonalcoholic fatty liver disease: An observational and mendelian randomization study.Nutr Metab Cardiovasc Dis. 2024 Dec;34(12):2705-2712. doi: 10.1016/j.numecd.2024.07.007. Epub 2024 Jul 15. Nutr Metab Cardiovasc Dis. 2024. PMID: 39168802
-
Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.Am J Kidney Dis. 2017 Nov;70(5):675-685. doi: 10.1053/j.ajkd.2017.05.021. Epub 2017 Jul 26. Am J Kidney Dis. 2017. PMID: 28754455 Free PMC article.
-
Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis.Diabetes Metab. 2019 Dec;45(6):536-544. doi: 10.1016/j.diabet.2019.04.008. Epub 2019 May 5. Diabetes Metab. 2019. PMID: 31067493
-
The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review.Eur J Gastroenterol Hepatol. 2021 May 1;33(5):745-751. doi: 10.1097/MEG.0000000000001967. Eur J Gastroenterol Hepatol. 2021. PMID: 33394807
Cited by
-
Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease.Medicine (Baltimore). 2019 May;98(18):e15362. doi: 10.1097/MD.0000000000015362. Medicine (Baltimore). 2019. PMID: 31045779 Free PMC article.
-
Prevalence of asymptomatic bronchiectasis and associations among the health screening population in South Korea.ERJ Open Res. 2021 Aug 2;7(3):00188-2021. doi: 10.1183/23120541.00188-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34350287 Free PMC article.
-
Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview.Metabolites. 2020 Nov 15;10(11):465. doi: 10.3390/metabo10110465. Metabolites. 2020. PMID: 33203192 Free PMC article. Review.
-
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease.Cells. 2021 Nov 1;10(11):2978. doi: 10.3390/cells10112978. Cells. 2021. PMID: 34831201 Free PMC article. Review.
-
Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).Int J Chron Obstruct Pulmon Dis. 2020 May 7;15:1005-1014. doi: 10.2147/COPD.S249534. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32440112 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical